Aperio Group, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$25,000
-10.7%
17,395
-12.3%
0.00%
Q4 2016$28,000
-73.1%
19,832
-66.5%
0.00%
-100.0%
Q3 2016$104,000
-21.8%
59,202
-23.8%
0.00%0.0%
Q2 2016$133,000
-13.6%
77,739
-0.6%
0.00%0.0%
Q1 2016$154,000
+32.8%
78,233
+27.7%
0.00%0.0%
Q4 2015$116,000
+5.5%
61,278
+6.1%
0.00%0.0%
Q3 2015$110,000
-52.6%
57,767
+15.6%
0.00%
-50.0%
Q2 2015$232,000
+6.9%
49,980
+0.5%
0.00%0.0%
Q1 2015$217,000
+26.9%
49,748
+0.8%
0.00%0.0%
Q4 2014$171,000
-16.6%
49,329
+0.7%
0.00%
-33.3%
Q3 2014$205,000
-28.1%
48,980
+0.6%
0.00%
-25.0%
Q2 2014$285,000
-10.7%
48,670
-3.8%
0.00%0.0%
Q1 2014$319,000
+13.1%
50,567
+4.9%
0.00%0.0%
Q4 2013$282,000
+8.5%
48,206
-2.3%
0.00%
-20.0%
Q3 2013$260,000
-34.2%
49,335
-3.8%
0.01%
-44.4%
Q2 2013$395,00051,3090.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders